MORGAN STANLEY (MS) 79.01 -0.85 (-1.06%)
79.01 -0.85 (-1.06%)
US6174464486 - Common Stock - After market: 79.02 +0.01 (+0.01%)
Buy % Consensus
Analysts have set a mean price target of 97.26. This target is 23.1% above the current price.
MS was analyzed by 36 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about MS.
In the previous month the buy percentage consensus was at a similar level.
MS was analyzed by 36 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-09-21 | Goldman Sachs | Maintains | Buy |
| 2022-09-21 | Credit Suisse | Maintains | Outperform |
| 2022-09-12 | Deutsche Bank | Maintains | Hold |
| 2022-09-06 | Odeon Capital | Downgrade | Hold -> Sell |
| 2022-07-15 | BMO Capital | Maintains | Outperform |
| 2022-07-15 | Oppenheimer | Maintains | Outperform |
| 2022-07-15 | Barclays | Maintains | Overweight |
| 2022-07-05 | Credit Suisse | Maintains | Outperform |
| 2022-07-01 | Wells Fargo | Maintains | Equal-Weight |
| 2022-07-01 | Piper Sandler | Maintains | Neutral |
| 2022-06-28 | RBC Capital | Maintains | Sector Perform |
| 2022-05-03 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2022-04-18 | BMO Capital | Maintains | Outperform |
| 2022-01-28 | Odeon Capital | Downgrade | Buy -> Hold |
| 2022-01-04 | UBS | Maintains | Buy |
| 2022-01-03 | Barclays | Maintains | Overweight |
| 2021-12-03 | Citigroup | Upgrade | Neutral -> Buy |
| 2021-10-25 | Wells Fargo | Maintains | Equal-Weight |
| 2021-10-15 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2021-10-15 | Barclays | Maintains | Overweight |
| 2021-10-15 | Credit Suisse | Maintains | Outperform |
| 2021-10-04 | Wells Fargo | Maintains | Equal-Weight |
| 2021-09-29 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2021-09-28 | Berenberg | Downgrade | Buy -> Hold |
| 2021-08-13 | Seaport Global | Downgrade | Buy -> Neutral |
| 2021-07-19 | Citigroup | Maintains | Neutral |
| 2021-07-16 | BMO Capital | Maintains | Outperform |
| 2021-07-16 | Argus Research | Maintains | Buy |
| 2021-07-16 | Oppenheimer | Maintains | Outperform |
| 2021-07-16 | Piper Sandler | Maintains | Neutral |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA